“We acquired actually fortunate about six years in the past after we began exploring how cannabinoids is likely to be used to deal with drug-resistant infections,” says Dr. Dana Lambert, CEO of Andira Prescription drugs, in an unique interview with Benzinga.
Dr. Lambert does not converse like an educational. Regardless of holding a Ph.D. in pharmaceutical sciences, she talks like somebody who has witnessed drugs fail firsthand. She started her profession as a hospital pharmacist, working with critically in poor health sufferers — folks battling most cancers, extreme infections and different situations the place present therapies usually fell quick.
She noticed, up shut, the restrictions of standard drugs, “significantly in relation to treating drug-resistant infections and cancer-related situations.”
However as a substitute of accepting these limitations as inevitable, she took a daring step: she left her scientific observe totally to pursue pharmaceutical analysis.
“I turned more and more fascinated about new therapeutic approaches, particularly as analysis began rising on the potential of cannabinoids in treating most cancers and antimicrobial-resistant infections,” she says.
That realization drove her to earn a Ph.D.; not as a result of she wished a profession in academia, however as a result of she wanted the instruments to create real-world options.
“I am in all probability the furthest factor from an educational scientist you may ever meet,” Lambert says. “I did it as a result of I wished to discover ways to develop medicine and become involved in early-stage analysis and drug discovery.”
What she and her staff at Andira Prescription drugs uncovered was one thing that would change how the world fights infections. The invention? Silvanex: a next-generation antimicrobial expertise that may very well be the reply to drug-resistant “superbugs.”
“Most conventional antimicrobials — whether or not they’re antibiotics, antifungals and even silver-based merchandise — finally lose effectiveness as a result of micro organism and fungi evolve resistance over time. That is how we ended up within the antimicrobial resistance (AMR) disaster we’re going through immediately,” Lambert explains.
See additionally: Germany’s Medical Hashish Growth: Costs Drop Beneath $4.20/Gram, Prescriptions Surge 1,000%
Antibiotic-resistant micro organism now kill greater than 1.27 million folks yearly, with drug-resistant infections contributing to almost 4.95 million deaths worldwide in 2019 alone. If left unaddressed, AMR could lead to greater than 39 million deaths between 2025 and 2050.
The financial penalties are simply as extreme. The World Financial institution estimates AMR may lead to a GDP lack of $1 trillion to $3.4 trillion yearly by 2030, with international healthcare prices rising by an extra $1 trillion by 2050. If no motion is taken, AMR could cause a 3.8% discount in international GDP, costing the world economy as much as $100 trillion by mid-century.
The rise of drug-resistant infections like methicillin-resistant Staphylococcus aureus (MRSA) and Candida auris has intensified the urgency for brand spanking new therapies.
Candida auris, particularly, has turn into one of the vital regarding fungal threats in trendy healthcare, as some strains have turn into proof against all obtainable antifungal therapies. “With antimicrobial resistance, silver-based merchandise simply aren’t reducing it anymore,” Lambert says. “They do not have the scientific efficacy wanted to guard folks from infections.”
Silver, as soon as thought of a promising antimicrobial various, additionally has limitations. It is extensively utilized in wound dressings, medical textiles, and coatings, however its effectiveness is modest at greatest. For years, researchers have been looking for methods to boost silver’s antimicrobial results with out rising its toxicity. That is precisely what Andira Prescription drugs got down to do.
Moderately than counting on silver alone, Andira Prescription drugs took a special strategy. Silvanex is predicated on a “triple-synergy” mechanism, combining silver with two cannabinoids: cannabichromene (CBC) and cannabigerol (CBG).
What makes it revolutionary is that as a substitute of simply barely bettering silver’s antimicrobial properties, the mixture will increase silver’s effectiveness by 800%.
“If you take cannabinoids by themselves, they might be efficient in opposition to some varieties of micro organism or fungi, however not others. That makes them unreliable as stand-alone antimicrobial brokers,” Lambert explains. “However when mixed with silver in the precise manner, the synergy makes silver exponentially more practical.”
See additionally: How Ozempic And Authorized Weed Are Altering What America Eats
Silvanex has proven potent antimicrobial exercise in opposition to a variety of dangerous micro organism — together with drug-resistant superbugs.
The invention did not cease there. Silvanex additionally proved extremely efficient in opposition to fungal pathogens, an space the place conventional antimicrobials have struggled.
“Some of the harmful fungal infections immediately is Candida auris. The state of affairs is so unhealthy that sure strains at the moment are proof against all obtainable antifungal drug therapies. That is why the CDC advises clinicians to contemplate investigational therapies for pan-resistant instances,” Lambert provides.
However Silvanex modified that equation.
“In contrast to standard antimicrobials, it not solely kills infectious microbes however might also assist forestall resistance from growing,” Lambert says.
With the stakes as excessive as they’re, the problem wasn’t simply making a more practical antimicrobial; it was guaranteeing Silvanex may very well be safely and effectively delivered to market. In contrast to conventional silver-based antimicrobials that require excessive doses to work, Silvanex achieves superior efficacy at considerably decrease concentrations.
That distinction is vital, as extreme silver publicity has been linked to delayed wound healing and cytotoxic effects.
Andira Prescription drugs’ strategy to drug growth was each rigorous and deliberate.
“We’re not simply making an attempt to introduce one other antimicrobial,” Lambert says. “We’re growing one thing that healthcare suppliers can belief — one thing that works higher than something presently obtainable and will be built-in into commonplace medical observe.”
See additionally: He Labored On Producing Oxygen On Mars, Now He Builds Hashish Robots: The Fascinating Story Of Sorting Robotics
Silvanex’s formulation is optimized for topical use, making it a robust candidate for wound care, surgical web site an infection prevention and hospital-acquired an infection management. In contrast to conventional antibiotics, which should be administered systemically and face vital challenges associated to drug resistance, Silvanex is designed to behave domestically, proper on the web site of an infection.
This topical strategy additionally addresses a serious limitation of cannabinoids in antimicrobial analysis: they lose their antimicrobial properties totally as soon as they enter the bloodstream.
“Cannabinoids lose their antimicrobial properties totally as soon as they enter systemic circulation,” Lambert explains. “That is why Silvanex will at all times be used as a topical therapy. The synergy between silver, CBC and CBG stays intact in exterior functions, the place we see the total good thing about its infection-fighting potential.”
Within the battle in opposition to hospital-acquired infections, this represents a serious leap ahead.
Bringing a novel drug to market requires extra than simply groundbreaking science: it calls for years of rigorous testing, regulatory approvals and a strategic path to commercialization.
Andira is now making ready to advance Silvanex by way of the subsequent vital phases of growth, beginning with scientific trials. The corporate’s pipeline of Silvanex product candidates features a topical drug formulated as an anti-infective cream, in addition to antimicrobial wound dressings. Based on Lambert, the wound dressings are on observe for regulatory submission as medical gadgets, which, if authorized, gives a quicker pathway to market in comparison with new drug functions.
The corporate is presently in preclinical testing, conducting important toxicology and security research to satisfy the stringent necessities set by regulatory businesses.
“Proper now, we’re a couple of 12 months away from coming into Section 1 scientific trials, and our objective is to progress by way of scientific growth as effectively as attainable,” Lambert says. “We have performed in depth preclinical testing and have seen promising outcomes in opposition to a number of drug-resistant pathogens, together with some on the FDA’s QIDP record. Whereas there is no assure, we imagine Silvanex has sturdy potential to qualify.”
With strategic partnerships within the works, Andira is positioning Silvanex not simply as an incremental enchancment, however as a possible paradigm shift in antimicrobial therapy.
The world is at a crossroads in relation to preventing superbugs. With out new options, drug-resistant infections may flip once-minor illnesses into lethal, untreatable threats.
Silvanex represents a possible breakthrough in an infection management, providing another the place conventional therapies have failed. By leveraging cannabinoids in a manner that enhances slightly than replaces present medical options, Andira Prescription drugs has developed a novel strategy to tackling antimicrobial resistance.
With Section 1 scientific trials on the horizon for the event of Silvanex as a topical drug product and strategic partnerships in movement for the event of Silvanex antimicrobial wound dressings, Andira goals to convey Silvanex to market as effectively as attainable. If profitable, this innovation may mark a turning level in an infection prevention, serving to to curb one of many best threats to international well being.
Photograph: Courtesy of Tinnakorn Jorruang by way of Shutterstock
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
